196 related articles for article (PubMed ID: 35141003)
1. Modulation of BRCA1 mediated DNA damage repair by deregulated ER-α signaling in breast cancers.
Rajan A; Varghese GR; Yadev I; Anandan J; Latha NR; Patra D; Krishnan N; Kuppusamy K; Warrier AV; Bhushan S; Nadhan R; Ram Kumar RM; Srinivas P
Am J Cancer Res; 2022; 12(1):17-47. PubMed ID: 35141003
[TBL] [Abstract][Full Text] [Related]
2. Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis.
Rajan A; Nadhan R; Latha NR; Krishnan N; Warrier AV; Srinivas P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188482. PubMed ID: 33260050
[TBL] [Abstract][Full Text] [Related]
3. Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining.
Beckta JM; Dever SM; Gnawali N; Khalil A; Sule A; Golding SE; Rosenberg E; Narayanan A; Kehn-Hall K; Xu B; Povirk LF; Valerie K
Oncotarget; 2015 Sep; 6(29):27674-87. PubMed ID: 26320175
[TBL] [Abstract][Full Text] [Related]
4. The Interplay between the Cellular Response to DNA Double-Strand Breaks and Estrogen.
Yedidia-Aryeh L; Goldberg M
Cells; 2022 Oct; 11(19):. PubMed ID: 36231059
[TBL] [Abstract][Full Text] [Related]
5. New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines.
Crowe DL; Lee MK
Breast Cancer Res; 2006; 8(1):R1. PubMed ID: 16417649
[TBL] [Abstract][Full Text] [Related]
6. Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy.
Vollebergh MA; Lips EH; Nederlof PM; Wessels LF; Wesseling J; Vd Vijver MJ; de Vries EG; van Tinteren H; Jonkers J; Hauptmann M; Rodenhuis S; Linn SC
Breast Cancer Res; 2014 May; 16(3):R47. PubMed ID: 24887359
[TBL] [Abstract][Full Text] [Related]
7. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.
Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 requirement for the fidelity of plasmid DNA double-strand break repair in cultured breast epithelial cells.
Thompson EG; Fares H; Dixon K
Environ Mol Mutagen; 2012 Jan; 53(1):32-43. PubMed ID: 22170030
[TBL] [Abstract][Full Text] [Related]
9. Functional crosstalk between DNA damage response proteins 53BP1 and BRCA1 regulates double strand break repair choice.
Bakr A; Köcher S; Volquardsen J; Reimer R; Borgmann K; Dikomey E; Rothkamm K; Mansour WY
Radiother Oncol; 2016 May; 119(2):276-81. PubMed ID: 26615718
[TBL] [Abstract][Full Text] [Related]
10. Targeting aberrant DNA double-strand break repair in triple-negative breast cancer with alpha-particle emitter radiolabeled anti-EGFR antibody.
Song H; Hedayati M; Hobbs RF; Shao C; Bruchertseifer F; Morgenstern A; Deweese TL; Sgouros G
Mol Cancer Ther; 2013 Oct; 12(10):2043-54. PubMed ID: 23873849
[TBL] [Abstract][Full Text] [Related]
11. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L
Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289
[TBL] [Abstract][Full Text] [Related]
12. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress.
Chroma K; Mistrik M; Moudry P; Gursky J; Liptay M; Strauss R; Skrott Z; Vrtel R; Bartkova J; Kramara J; Bartek J
Oncogene; 2017 Apr; 36(17):2405-2422. PubMed ID: 27841863
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP).
Rosen DB; Leung LY; Louie B; Cordeiro JA; Conroy A; Shapira I; Fields SZ; Cesano A; Hawtin RE
J Transl Med; 2014 Jun; 12():184. PubMed ID: 24965603
[TBL] [Abstract][Full Text] [Related]
14. Harnessing DNA Double-Strand Break Repair for Cancer Treatment.
Trenner A; Sartori AA
Front Oncol; 2019; 9():1388. PubMed ID: 31921645
[TBL] [Abstract][Full Text] [Related]
15. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.
Zhuang J; Zhang J; Willers H; Wang H; Chung JH; van Gent DC; Hallahan DE; Powell SN; Xia F
Cancer Res; 2006 Feb; 66(3):1401-8. PubMed ID: 16452195
[TBL] [Abstract][Full Text] [Related]
16. Unveiling the relationship between WWOX and BRCA1 in mammary tumorigenicity and in DNA repair pathway selection.
Bidany-Mizrahi T; Shweiki A; Maroun K; Abu-Tair L; Mali B; Aqeilan RI
Cell Death Discov; 2024 Mar; 10(1):145. PubMed ID: 38499540
[TBL] [Abstract][Full Text] [Related]
17. Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.
Alli E; Sharma VB; Sunderesakumar P; Ford JM
Cancer Res; 2009 Apr; 69(8):3589-96. PubMed ID: 19351835
[TBL] [Abstract][Full Text] [Related]
18. Unsolved mystery: the role of BRCA1 in DNA end-joining.
Saha J; Davis AJ
J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i18-i24. PubMed ID: 27170701
[TBL] [Abstract][Full Text] [Related]
19. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation.
Stecklein SR; Kumaraswamy E; Behbod F; Wang W; Chaguturu V; Harlan-Williams LM; Jensen RA
Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13650-5. PubMed ID: 22869732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
